What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series.
暂无分享，去创建一个
F. Montorsi | G. Gandaglia | A. Briganti | J. Futterer | P. Sooriakumaran | V. Ficarra | P. Ghadjar | P. D. De Visschere | G. Giannarini | P. Ost | C. Massard | H. Isbarn | N. Suardi | C. Surcel | G. Ploussard | R. V. D. van der Bergh | Roderick C N van der Bergh